Artificial Intelligence in Healthcare

The global AI in healthcare market is anticipated to reach $35,892.2 Million by 2030, registering a CAGR of 24.40%, during the forecast period 2021-2030. Owing to the COVID pandemic, the market grew with a significant growth rate in 2020. The global lockdown and social distancing norms highlighted the importance of remote monitoring, telemedicine, and technology integration in the primary healthcare system, which accelerated the market growth in 2020.

Market Segmentation

• Product Type (AI-Integrated Hardware and Software and Services)

• Technology (Machine Learning, Deep Learning, Natural Language Processing, Computer Vision, and Others)

• Application (Medical Imaging and Diagnosis, Data Management, Telemedicine, Remote Monitoring and Lifestyle Management, Robot-Assisted Surgery, Drug Discover and Clinical Trials, Virtual Assistance, and Others)

• End User (Patients, Healthcare Providers, Academic Institutes and Research Centers, Pharmaceutical Companies, Healthcare Insurance, and Others)

Regional Segmentation

• North America

• Europe

• Asia-Pacific

• Rest-of-the-World

Growth Drivers

• Growing Need for Patient-Centric Care

• Growing Applications of AI in Healthcare Informatics

• Shortage of Healthcare Workforce

• Increasing Complexities of Clinical Decision Making

• Progress in Healthcare IT

Market Restraints

• Lack of Clearly Defined Regulations

• Data Security and Privacy Concerns

• Barriers to Physician’s Adoption of AI

• Legal Implications of AI Systems

Market Opportunities

• Capitalizing on Unmet Clinical Demand

• Enabling Care At-Home: Remote Monitoring

• Leveraging Rapid Development in Deep Learning

• Unlocking the Combined Potential of AI and Robotics

Key Companies Profiled

Activ Surgical, Inc., Atomwise, Inc., Babylon Health, BenevolentAI, Butterfly Network, Inc., Freenome, General Electric Company, International Business Machines Corporation (IBM), Koninklijke Philips N.V., Nuance Communications, Inc., Nvidia Corporation, Olive, Siemens Healthineers AG, Viz.ai, Inc., and Zebra Medical Vision Ltd.

Request a Sample - https://bisresearch.com/requestsample?id=1068&type=download

Comments

Clinical Decision Support Systems (CDSS) Market registering a CAGR of 6.70% during the forecast period 2021-2030

The global market for clinical decision support systems (CDSS) registered the market value of $1,918.8 million in 2020 and is expected to reach $3,739.2 million by 2030, registering at a CAGR of 6.70% during the forecast period 2020-2030. The clinical decision support systems of the future are expected to be developed to leverage data to make observations which are not interpretable by humans. Healthcare IT systems in the future are expected to leverage cutting-edge technology as an enabler to make clinical care more streamlined and accurate. The technology is still in its nascent stage. One of the strong points of this technology is that it improves with time. Continuous input from clinicians, patients, and other stakeholders will be essential for correctly implementing the technology to enhance meaningful uses, reduce costs, and improve treatment outcomes. Key USPs of the Report Following are some of the key contents of the report: • Industry Analysis ...

Microbiome Therapeutics Market Growth, Segmentation, Opportunity and Forecast to 2032

Global microbiome therapeutics market is expected to grow further in the coming years due to the continuous increase in awareness and need for better and safer treatment alternatives and the dominance of gastrointestinal (GI) and infectious diseases segment can be attributed to the existing dominance of microbiome therapeutics available for a variety of indications ranging from diarrhea and gut dysbiosis to skin disorders, cancer indications among others. The global microbiome therapeutics market which accounted for $306.3 million in 2021 is expected to reach $3,204 million by 2032, reporting a CAGR of 24.95% during the forecast period 2022-2032. The existing microbiome therapeutics market is favored by multiple factors, including the rising geriatric populations coupled with the increasing adoption of inorganic growth strategies by key players in the market. Impact of COVID-19 There were numerous consequences due to the COVID-19 pandemic, especially...

Hyperspectral Imaging Market Projections , Upcoming Trends Focus on Long-Term Impact of Covid-19 and Forecast By 2027

The global hyperspectral imaging market was estimated to be at $791.2 million in 2021, which is expected to grow with a CAGR of 13.17% and reach $1,640.3 million by 2027.The growth in the global hyperspectral imaging market is expected to be primarily driven by increased awareness of the technology in different sectors such as agriculture, healthcare, and mining. The hyperspectral imaging technology has great potential, and the market is anticipated to grow during the forecast period owing to the widespread applications of HSI, increasing investments for RD activities, increasing demand from military and defense sectors, increased food safety concerns, and increasing awareness regarding early diagnosis of diseases. COVID-19 Impact and Post-COVID-19 Scenario The COVID-19 pandemic had a debilitating impact on the global ecosystem. The pandemic led to a shutdown of production facilities, which do not come under essential goods, which led to a negative impact on se...

Market Research Reports

Search This Blog